Literature DB >> 6343402

Epithelial layer formation in differentiating aggregates of F9 embryonal carcinoma cells.

A Grover, R G Oshima, E D Adamson.   

Abstract

F9 embryonal carcinoma (EC) cells, cultured in suspension in medium containing 5 X 10(-8) M retinoic acid, aggregate and differentiate into embryoid bodies with an outer layer of visceral endoderm cells that synthesize and secrete alphafetoprotein (AFP) (Hogan, B. L. M., A. Taylor, and E. Adamson, 1981, Nature (Lond.). 291:235-237). Here we analyze the formation of the outer layer of cells as a model for epithelial differentiation. Three morphological phases are described, but analyses of cell numbers and the synthetic rates of some proteins, as well as the appearance of markers of visceral endoderm and basement membrane, show that the formation of the outer layer occurs as an orderly progression of multiple events. The markers used to follow the ontogeny of epithelial layer formation include SSEA-1, l, and i blood group antigens, laminin, fibronectin, type IV collagen, cytoskeletal intermediate filament proteins (vimentin, Endo A, and B), and AFP. The onset of epithelium formation occurs between the third and fourth day of culture, but its function is maximally expressed only when it is well organized. We found the rate of AFP secretion to be a measure of the proper alignment and maturity of the epithelium which occurs at the seventh or eighth day. This model of epithelium formation may help to explain how similar processes occur during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343402      PMCID: PMC2112462          DOI: 10.1083/jcb.96.6.1690

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  26 in total

1.  An octamer of histones in chromatin and free in solution.

Authors:  J O Thomas; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

2.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Localization and synthesis of alphafoetoprotein in post-implantation mouse embryos.

Authors:  M Dziadek; E Adamson
Journal:  J Embryol Exp Morphol       Date:  1978-02

5.  Interaction of fibronectin with antibodies and collagen in radioimmunoassay.

Authors:  E Ruoslahti; M Vuento; E Engvall
Journal:  Biochim Biophys Acta       Date:  1978-06-21

6.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1).

Authors:  D Solter; B B Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

7.  Relationship of the biosynthesis of alpha-fetoprotein, albumin, hemopexin, and haptoglobin to the growth state of fetal rat hepatocyte cultures.

Authors:  S Sell; H Skelly; H L Leffert; U Muller-Eberhard; S Kida
Journal:  Ann N Y Acad Sci       Date:  1975-08-22       Impact factor: 5.691

8.  Alkaline phosphatase activity in mouse teratoma.

Authors:  E G Berstine; M L Hooper; S Grandchamp; B Ephrussi
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

9.  Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture.

Authors:  K Artzt; P Dubois; D Bennett; H Condamine; C Babinet; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

10.  Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro.

Authors:  G R Martin; M J Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

View more
  29 in total

1.  FoxA proteins regulate H19 endoderm enhancer E1 and exhibit developmental changes in enhancer binding in vivo.

Authors:  Lingyun Long; Brett T Spear
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

2.  Nuclear receptors for retinoic acid and thyroid hormone regulate transcription of keratin genes.

Authors:  M Tomic; C K Jiang; H S Epstein; I M Freedberg; H H Samuels; M Blumenberg
Journal:  Cell Regul       Date:  1990-11

3.  Suppression of endo B cytokeratin by its antisense RNA inhibits the normal coexpression of endo A cytokeratin.

Authors:  K Trevor; E Linney; R G Oshima
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

4.  Undifferentiated F9 embryonal carcinoma cells produce a short-chain collagen molecule.

Authors:  B D Smith; C T Baldwin
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

5.  Differential regulation of viral and cellular genes in F9 mouse embryonal carcinoma cells.

Authors:  M J Sleigh
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

6.  Conditions affecting the differentiation of F9 teratocarcinoma cells: potentiation of response by cyclic AMP.

Authors:  A Grover; E D Adamson
Journal:  In Vitro Cell Dev Biol       Date:  1986-05

7.  Embryonic expression of the human 40-kD keratin: evidence from a processed pseudogene sequence.

Authors:  E S Savtchenko; T A Schiff; C K Jiang; I M Freedberg; M Blumenberg
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

8.  Carbohydrate antigen expression in murine embryonic stem cells and embryos. I. Lacto and neo-lacto determinants.

Authors:  D G Brown; V N Warren; P Påhlsson; S J Kimber
Journal:  Histochem J       Date:  1993-06

9.  Maintenance of pluripotency in mouse embryonic stem cells persistently infected with murine coronavirus.

Authors:  A Okumura; K Machii; S Azuma; Y Toyoda; S Kyuwa
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Loss of Oct4 expression during the development of murine embryoid bodies.

Authors:  Abdulrahim A Sajini; Lucas V Greder; James R Dutton; Jonathan M W Slack
Journal:  Dev Biol       Date:  2012-08-31       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.